Kymera Therapeutics (KYMR) Stock Price
Kymera Therapeutics Price
Revenue has compounded at 54.0% per year over the past 6 years to 39.20 M USD. Kymera Therapeutics's net margin stands at -794.4%, down from -137.6% several years earlier. Analysts set a median price target of 135.00 USD, implying 19.9% above the current price. Of 30 analysts, 26 rate the stock a buy — an overall Buy consensus.
Kymera Therapeutics stock price
Kymera Therapeutics business model & stock analysis
Frequently asked questions about Kymera Therapeutics
Analysts currently set an average price target of 129.64 USD for the Kymera Therapeutics stock (median: 135.00 USD), implying +15.1 % versus the latest price. The consensus is based on 30 analyst ratings.
30 analysts currently rate the Kymera Therapeutics stock: 26 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Kymera Therapeutics to generate revenue of 105.03 M USD and earnings per share of -3.64 USD.
Converted at the current exchange rate, the Kymera Therapeutics share trades at 100.46 EUR (112.59 USD).
The Kymera Therapeutics share (KYMR) is listed on 1 stock exchanges, including: NASDAQ (KYMR).
The expected revenue of Kymera Therapeutics is 105.03 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Kymera Therapeutics is -306.86 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Kymera Therapeutics is currently -30.96. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Kymera Therapeutics stock.
The price-to-sales ratio (P/S) of Kymera Therapeutics is currently 90.46. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Kymera Therapeutics stock.
The Eulerpool Quality Score for Kymera Therapeutics is 2/10.
The ISIN of Kymera Therapeutics is US5015751044. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Kymera Therapeutics is KYMR. The ticker symbol is used to trade Kymera Therapeutics shares on the stock exchange.
Kymera Therapeutics stock
Kymera Therapeutics Peer Group
Kymera Therapeutics Ticker
Kymera Therapeutics FIGI
All fundamentals and in-depth analysis of Kymera Therapeutics
Our stock analysis for Kymera Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kymera Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.